Genedrive PLC Director/PDMR Shareholding (1217C)

TIDMGDR

RNS Number : 1217C

Genedrive PLC

05 February 2020

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that Lisa Miele, a Person Closely Associated with Gino Miele R&D Director and a PDMR, acquired 8,636 ordinary shares of 1.5p each ("Ordinary Shares") in the Company at a price of 8.875p per today.

Following these purchases, Gino Miele's total beneficial interest is 66,979 Ordinary Shares, 0.2% of the issued share capital of the Company.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 
            1.   Details of the person discharging managerial responsibilities 
                  / person closely associated 
      a.         Name                                       Lisa Miele 
                ------------------------------  ---------------------------------------- 
            2.   Reason for the notification 
                ------------------------------------------------------------------------ 
            a.   Position/status                 PCA of Gino Miele R&D Director 
                ------------------------------  ---------------------------------------- 
            a.   Initial notification            Initial notification 
                  /Amendment 
                ------------------------------  ---------------------------------------- 
      3.         Details of the issuer, emission allowance market participant, 
                  auction platform, auctioneer or auction monitor 
                ------------------------------------------------------------------------ 
            a.   Name                            genedrive plc 
                ------------------------------  ---------------------------------------- 
            b.   LEI                             213800ZYODIRZ87Y4K14 
                ------------------------------  ---------------------------------------- 
            4.   Details of the transaction(s): section to be repeated for 
                  (i) each type of instrument; (ii) each type of transaction; 
                  (iii) each date; and (iv) each place where transactions 
                  have been conducted 
                ------------------------------------------------------------------------ 
            a.   Description of                  Ordinary shares of 1.5 pence each 
                  the 
                  Financial instrument, 
                  type 
                  of instrument                   GB00B1VKB244 
                  Identification 
                  code 
                ------------------------------  ---------------------------------------- 
            b.   Nature of the                              Purchase 
                  transaction 
                ------------------------------  ---------------------------------------- 
            c.   Price(s) and                               Price(s)          Volume(s) 
                  volume(s)                                    8.875p              8,636 
                                                                       ----------------- 
                ------------------------------  ---------------------------------------- 
            d.        Aggregated information 
                        *    Aggregated volume     N/A 
 
 
                        *    Price 
                ------------------------------  ---------------------------------------- 
            e.   Date of the transaction         2020-02-05 
                ------------------------------  ---------------------------------------- 
            f.   Place of the                    London Stock Exchange, AIM 
                  transaction 
                ------------------------------  ---------------------------------------- 
 

For further details please contact:

 
 genedrive plc                                                               [phone] 
 David Budd: CEO / Matthew Fowler: 
  CFO 
 
 Peel Hunt LLP (Nominated Adviser and 
  Joint Broker)                                                              [phone] 
 James Steel / Oliver Jackson 
 
            Stanford Capital Partners Limited 
             (Joint Broker)                                                  [phone] 
            Patrick Claridge / John Howes 
 
 Walbrook PR Ltd (Media Relations &              [phone] or [e-mail] 
  Investor Relations) 
                                                               [phone] / +44 (0)7876 
 Paul McManus / Anna Dunphy                                                              741 001 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHEAXASEDDEEFA

(END) Dow Jones Newswires

February 05, 2020 12:39 ET (17:39 GMT)